Showing results (71-80 of 1,983) with videos related to

Sort By:
Pageof 199
Journal of Cancer|January 6, 2021
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerYiqun Han, Jiayu Wang, Binghe Xu
Breast (Edinburgh, Scotland)|September 26, 2020
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysisYiqun Han, Jiayu Wang, Binghe Xu
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 27, 2024
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancementMingxia Jiang, Qiao Li, Binghe Xu
Thoracic Cancer|April 13, 2017
Timing of paclitaxel treatment in pre-operative or post-operative does not affect survival in breast cancer patientsJiayu Wang, Shanshan Chen, Binghe Xu, et al.
JAMA Network Open|February 24, 2023
Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer: A Randomized Clinical TrialPeng Yuan, Yikun Kang, Fei Ma, et al.
Therapeutic Advances in Medical Oncology|June 11, 2020
Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort studyXue Wang, Anjie Zhu, Jiayu Wang, et al.
Clinical Breast Cancer|August 12, 2022
Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast CancerJiani Wang, Qing Li, Yang Luo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 9, 2026
Spatial transcriptome revealed associated biomarkers for endocrine therapy response in HR-positive/HER2-negative early breast cancerYujing Tan, Jiani Wang, Zhe Chen, et al.
Breast Cancer Research and Treatment|April 25, 2021
Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trialZijing Wang, Jiaxuan Liu, Fei Ma, et al.
Annals of Surgical Oncology|January 24, 2020
Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of LifeYiran Si, Peng Yuan, Nanlin Hu, et al.
Pageof 199